Melibiase en es it fr

Melibiase Brand names, Melibiase Analogs

Melibiase Brand Names Mixture

  • No information avaliable

Melibiase Chemical_Formula


Melibiase RX_link

Melibiase fda sheet

Melibiase msds (material safety sheet)

Melibiase Synthesis Reference

No information avaliable

Melibiase Molecular Weight


Melibiase Melting Point

No information avaliable

Melibiase H2O Solubility

No information avaliable

Melibiase State


Melibiase LogP


Melibiase Dosage Forms

Powder for solution

Melibiase Indication

For treatment of Fabry's disease (alpha-galactosidase A deficiency)

Melibiase Pharmacology

Used in the treatment of Fabry disease, an X-linked genetic disorder of glycosphingolipid metabolism. The disease is characterized by a deficiency of the lysosomal enzyme alpha-galactosidase A, which leads to progressive accumulation of glycosphingolipids, predominantly GL-3, in many body tissues. Clinical manifestations of Fabry disease include renal failure, cardiomyopathy, and cerebrovascular accidents. Fabrazyme is intended to provide an exogenous source of alpha-galactosidase A and to limit the accumulation of these glycolipids in the tissues.

Melibiase Absorption

No information avaliable

Melibiase side effects and Toxicity

No information avaliable

Melibiase Patient Information


Melibiase Organisms Affected

Humans and other mammals